Type
IV Vitamin Therapy
Duration
1 hour
What's included
5 deliverables in this treatment
- Citicoline (CDP-choline) in therapeutically dosed IV formulation
- Cerebrolysin neuropeptide complex via intravenous route
- 60-minute supervised infusion session in clinical setting
- Pre-course neurological history review and contraindication screening
- Medical oversight throughout administration
The Brain Power Infusion at ARCADA Medicentrum delivers two of the most clinically researched neuroprotective compounds — Citicoline and Cerebrolysin — directly into the bloodstream. Citicoline (CDP-choline) is a naturally occurring compound that supports phosphatidylcholine synthesis in neuronal membranes, enhancing acetylcholine neurotransmission and protecting neurons from ischaemic damage. Cerebrolysin is a neuropeptide mixture derived from porcine brain protein concentrate, used in neurological medicine for acute ischaemic stroke, traumatic brain injury, and cognitive decline — with a multi-decade European clinical evidence base. Together, they form a powerful synergistic protocol for individuals managing brain injury recovery, cognitive deterioration, or post-stroke neurological deficits. At ARCADA, this infusion is offered in the context of a clinic deeply experienced in neurological rehabilitation.
About this treatment
The Brain Power Infusion at ARCADA Medicentrum combines two pharmaceutically distinct neuroprotective agents that have complementary mechanisms of action:
Citicoline (CDP-choline)
A naturally occurring intermediate in the biosynthesis of phosphatidylcholine, the dominant phospholipid in neuronal membranes. IV Citicoline has demonstrated in clinical trials to: stabilise neuronal membrane integrity after ischaemic injury, enhance cerebral blood flow, increase dopamine and norepinephrine levels (supporting alertness, motivation, and mood), and accelerate neural recovery after stroke. It has a well-established European safety profile…
Good to know
- Compound 1
- Citicoline (CDP-choline)
- Compound 2
- Cerebrolysin (neuropeptide mixture)
- Clinical evidence
- RCT-backed for stroke, TBI, vascular dementia
- Duration
- 60 minutes per session
- Recommended course
- 10–20 sessions (neurological); 5 sessions (cognitive)
Who is this for?
Post-stroke recovery, traumatic brain injury, cognitive decline, vascular dementia, hypoxic brain injury, neuroprotection, cognitive performance optimisation
Preparation required
Inform staff of all current medications (especially blood thinners or anticoagulants). Bring any neurological imaging or recent test results. Avoid alcohol for 48 hours before each session. Epilepsy history requires physician review before starting the course.
About the clinic
Reviews, team and credentials
Independent review links and clinic-reported team information.
Clinical team
The rehabilitation team is headed by Mgr. Abdallah Walweel, Head of Rehabilitation at ARCADA. Clinic operations are managed by Martina Krákorová (ARCADA Ostrava) and Markéta Vláčilová (Wachkoma unit). The massage and physical therapy team includes certified therapist Arina Kobzysta. The Medicentrum neurological outpatient branch operates under a qualified neurologist for both adult and paediatric patients, with EEG…
Clinic-reported credentials
Languages: Czech, English
What clients say
"Davídek came to ARCADA with a diagnosis of cerebral palsy. After intensive neurorehabilitation, his motor development improved in ways his family had not expected — ARCADA's team worked with him individually every day of the 14-day block. (Patient story from arcada-center.com)"
"Kamilka's story shows what intensive therapy can achieve: consistent progress across multiple programme blocks, with the ARCA cage and TheraSuit method making the difference for her movement control. (Patient story from arcada-center.com)"
Treatment highlights
- Citicoline (CDP-choline) in therapeutically dosed IV formulation
- Cerebrolysin neuropeptide complex via intravenous route
+3 more items in What's included
Approx. 3 500 Kč per session (contact clinic for current pricing: +420 604 772 988). Includes Citicoline and Cerebrolysin — prescription-grade neuropeptide compounds administered in a supervised clinical setting. Course of 10–20 sessions typically recommended for neurological indications.